2017
DOI: 10.1097/yct.0000000000000443
|View full text |Cite
|
Sign up to set email alerts
|

Bifrontal Electroconvulsive Therapy in a Patient With Subcallosal Cingulate Deep Brain Stimulation for Depression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(12 citation statements)
references
References 3 publications
0
12
0
Order By: Relevance
“…In most of the cases of BF or BT ECT with DBS, the authors reported good cognitive tolerability of ECT, without major adverse effects 3,25,27–33,35,36,38–42 . Among those adverse effects that were reported, there were 2 cases of transient confusion, 24,26 1 case of short-term memory impairment that resolved 4 weeks after the ECT program, 23 and 1 case of significant memory impairment leading to discontinuation of BF ECT 37 . However, it should be noted that the latter case concerned a woman who had already undergone ECT treatment, very poorly tolerated, before DBS.…”
Section: Resultsmentioning
confidence: 97%
See 4 more Smart Citations
“…In most of the cases of BF or BT ECT with DBS, the authors reported good cognitive tolerability of ECT, without major adverse effects 3,25,27–33,35,36,38–42 . Among those adverse effects that were reported, there were 2 cases of transient confusion, 24,26 1 case of short-term memory impairment that resolved 4 weeks after the ECT program, 23 and 1 case of significant memory impairment leading to discontinuation of BF ECT 37 . However, it should be noted that the latter case concerned a woman who had already undergone ECT treatment, very poorly tolerated, before DBS.…”
Section: Resultsmentioning
confidence: 97%
“…Case reports showed that ECT can be performed-using the MECTA spECTrum 5000 29,30,34,38,41 or Thymatron 3,23,24,26,31,32,35,[37][38][39]41,42 devices-in patients with DBS targeting the subthalamic nucleus, 3,24,26,29,30,32,34,35,38,39,41 the internal globus pallidus, 3,31 or the VIM, 23,25,42 for the treatment of movement disorders. In 1 case, the DBS target for a patient with PD was not specified.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations